Kinetics of atrial natriuretic peptide in young and elderly subjects
- PMID: 1387608
- DOI: 10.1007/BF00280134
Kinetics of atrial natriuretic peptide in young and elderly subjects
Abstract
To study the influence of age on the kinetics of atrial natriuretic peptide (ANP) in man, human (99-126) ANP 2.0 micrograms.min-1 was infused IV for 60 min in 8 healthy young (18 to 25 y) and 9 healthy elderly (71 to 84 y) subjects. Both baseline ANP values and the levels at the end of infusion were higher in the elderly subjects. The mean residence time of ANP in the two age groups was not significantly different, whereas total body clearance (CL) was markedly diminished in the elderly as compared to the young subjects (mean +/- SD 3.1 +/- 1.0 l.min-1 and 6.2 +/- 4.1 l.min-1, respectively). The apparent volume of distribution at steady state was lower in the elderly than in the young, but the difference was not significant (mean +/- SD 44 +/- 19 and 103 +/- 111, respectively. The decrease in CL largely explained the higher ANP levels found in the elderly subjects. The MRT and the plasma half-life of the terminal phase did not differ between the two groups. In the elderly but not in the young subjects the calculated endogenous creatinine clearance was closely correlated with the CL (r = 0.90, P less than 0.001), thereby emphasizing the importance of the kidney in the metabolic clearance of ANP in the elderly.
Similar articles
-
Comparison of cyclic guanosine monophosphate response to infusion of atrial natriuretic peptide in young and elderly subjects.J Am Geriatr Soc. 1993 Nov;41(11):1241-4. doi: 10.1111/j.1532-5415.1993.tb07309.x. J Am Geriatr Soc. 1993. PMID: 8227900 Clinical Trial.
-
Effect of posture on clearance of atrial natriuretic peptide from plasma.J Clin Endocrinol Metab. 1987 Dec;65(6):1095-7. doi: 10.1210/jcem-65-6-1095. J Clin Endocrinol Metab. 1987. PMID: 2960688
-
Hemodynamic effects of atrial natriuretic factor in young and elderly subjects.Clin Pharmacol Ther. 1990 Aug;48(2):179-88. doi: 10.1038/clpt.1990.133. Clin Pharmacol Ther. 1990. PMID: 2143129 Clinical Trial.
-
Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man.Life Sci. 1986 May 19;38(20):1827-33. doi: 10.1016/0024-3205(86)90137-2. Life Sci. 1986. PMID: 2939312
-
Effect of low dose infusions of ile-atrial natriuretic peptide in healthy elderly males: evidence for a postreceptor defect.J Clin Endocrinol Metab. 1993 May;76(5):1271-4. doi: 10.1210/jcem.76.5.8388403. J Clin Endocrinol Metab. 1993. PMID: 8388403 Clinical Trial.
Cited by
-
The aging kidney: a review -- part I.Int Urol Nephrol. 2005;37(1):185-205. doi: 10.1007/s11255-004-0873-6. Int Urol Nephrol. 2005. PMID: 16132784 Review. No abstract available.
-
Raised plasma levels of atrial natriuretic factor in cardiac allograft recipients: evidence of increased cardiac secretion and decreased renal clearance.Eur J Clin Pharmacol. 1995;48(6):429-34. doi: 10.1007/BF00194330. Eur J Clin Pharmacol. 1995. PMID: 8582459 Clinical Trial.
-
Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients-signs of volume overload.Clin Rheumatol. 2017 May;36(5):1041-1051. doi: 10.1007/s10067-016-3286-x. Epub 2016 Apr 26. Clin Rheumatol. 2017. PMID: 27112146
-
Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics.Clin Pharmacokinet. 1993 Jan;24(1):28-45. doi: 10.2165/00003088-199324010-00003. Clin Pharmacokinet. 1993. PMID: 8448971 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous